This microRNA is capable of promoting lung cancer by subexpressing several regulators (SPRED1, SPRED2, SPRY1, RASA1, SPRY3 and SPRY4) in RAS / MAPK signaling, which leads to an increase in the signaling of this pathway. This evidence concerns the gene SPRY1 and lung cancer.